6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
14m ago	e.l.f. Cosmetics Joins the International Dance League as Founding Partner to Put Dancers Center Stage
45m ago	TDG Gold Appoints Paul Geddes as Senior Vice-President Business Development and Strategy
45m ago	Meryllion Resources Announces New Non-Brokered LIFE Financing
45m ago	Mkango Resources Announces Opening of Hypromag Plant in Pforzheim
45m ago	Aurania Resources Enters into Agreement with St-Georges to Jointly Advance the Thor Epithermal Gold Project in Iceland

About

Arrivent Biopharma, Inc. Common Stock (NASDAQ:AVBP) — investor relations, events, news, and company updates on 6ix.

Latest News

ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting

ArriVent BioPharma Reports Full Year 2025 Financial Results

ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer

ArriVent BioPharma Reports Third Quarter 2025 Financial Results

ArriVent Appoints Brent S. Rice as Chief Commercial Officer

Financials

Revenue

$0

Market Cap

$1.1 B

EPS

-4.32

Community Chat

Ask AI